This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Towa Pharmaceutical Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Tatsuya Honjo: Innovator in Pharmaceutical Composition
Introduction
Tatsuya Honjo is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the effectiveness of oral medications through advanced formulations.
Latest Patents
Tatsuya Honjo holds a patent for "Timed-elution masking particles and oral pharmaceutical composition containing the same." This invention involves masking particles that comprise a drug-containing particle, which includes a drug, an acid, and a carbonate. The unique design of these particles allows for the suppression of drug release in the oral cavity and pharynx, enabling rapid drug release after swallowing. This innovation facilitates better control over the release suppression time of the drug, making it a valuable advancement in oral pharmaceutical compositions, which can include tablets, granules, fine granules, and powders. He has 1 patent to his name.
Career Highlights
Tatsuya Honjo is associated with Towa Pharmaceutical Co., Ltd., where he continues to contribute to pharmaceutical innovations. His expertise in drug formulation and delivery systems has positioned him as a key figure in the industry.
Collaborations
Throughout his career, Tatsuya has collaborated with talented individuals such as Megumi Murahashi and Masaki Sato. These collaborations have further enriched his work and contributed to the success of his projects.
Conclusion
Tatsuya Honjo's innovative approach to pharmaceutical compositions exemplifies the importance of advancements in drug delivery systems. His contributions are paving the way for more effective oral medications, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile